Sep 8, 2015 · RVd or VRd is given to alleviate myeloma symptoms and slow the progression of multiple myeloma, not to cure this disease. After treatment, patients who respond to RVd typically are either monitored, continue on to maintenance therapy, or proceed to bone marrow transplant.
Jun 3, 2024 · Bortezomib, lenalidomide, and dexamethasone ( VRd ) is a preferred first-line treatment option for patients with newly diagnosed multiple myeloma. Whether the addition of the anti-CD38 monoclonal...
Apr 27, 2022 · VRd is a treatment for multiple myeloma, a type of blood cancer. It is sometimes called RVd. VRd comprises the drugs Velcade, Revlimid, and dexamethasone.
Dec 12, 2023 · The addition of subcutaneous daratumumab to VRd induction and consolidation therapy and to lenalidomide maintenance therapy conferred a significant benefit with respect to progression-free ...
The DVRd Regimen | International Myeloma Foundation
Apr 30, 2026 · At 54 months, approximately 68% of study patients in the DVRd arm remained progression-free vs. approximately 48% in the VRd arm. DVRd demonstrated a 43% lower risk of progression or death when compared to the VRd arm of the study.